Quanterix's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Quanterix's ROA in the second quarter of 2026?
Quanterix Corporation recorded a cumulative net loss of $-123 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -31.79%.

However, within the Healthcare sector 435 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3564, from total ROA ranking in the first quarter of 2026 at 4203.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-14.9 %	-7.53 %	6.73 %	11.76 %	-6.02 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-123	-104	-107	-96	-70
Return On Assets (TTM)	-31.79 %	-25.96 %	-26.21 %	-23.79 %	-18.05 %
QTRX's Total Ranking	# 3564	# 4203	# 3624	# 3525	# 3385
Total Assets (TTM) in million	320	367	419	444	376
Seq. Total Assets Change	-12.83 %	-12.44 %	-5.71 %	18.25 %	-5.27 %
Seq. Net Income Change	-	-	-	-	-

QTRX's 5 Years Annual ROA >> Back to QTRX Management Effectiveness >> Compare QTRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 20
Sector	# 436
Overall	# 3639

Return On Assets Statistics
High	Average	Low
-6.53 %	-19.62 %	-44.11 %
(Dec 31 2023)		(Mar 31 2019)

Financial Statements
Quanterix's Assets	$ 320 million	QTRX's Balance sheet
Quanterix's Income	$ -49 million	Quarterly QTRX's Income Statement
QTRX's Income by Division		See QTRX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	7.16 %	-4.93 %	-49.45 %	-8.36 %	237.76 %
Total Assets in million	419	391	411	813	887
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-107	-39	-28	-97	-56
Annual Return On Assets	-25.59 %	-9.86 %	-6.9 %	-11.89 %	-6.26 %

QTRX's 5 Years Annual ROA >> Back to QTRX Management Effectiveness >> Compare QTRX ROA to its Competitors

More Return On Assets Ratios
QTRX's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
QTRX's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for QTRX's Competitors
Subscribers only: Roa for Quanterix's Suppliers
Subscribers only: Return On Assets for QTRX's Customers

You may also want to know
QTRX's Roi	QTRX's Inventory Turnover Ratio	QTRX's Growth Rates	QTRX's Dividend Comparisons
	QTRX's Profitability Ratios	QTRX's Asset Turnover Ratio	QTRX's Dividend Growth
QTRX's Roe	QTRX's Valuation Ratios	QTRX's Financial Strength Ratios	QTRX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T20:23:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.